Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros








Intervalo de año
1.
Artículo en Inglés | IMSEAR | ID: sea-151613

RESUMEN

The present research work deals with the in- vitro dissolution study of developed sol to gel ocular drug delivery system of brimonidine for conjunctivitis during accelerated stability study. The formulation of brimonidine was developed and optimized formulation coded as X4Y2D containing optimized amount of sodium alginate and HPMC K100LvP was evaluated for the physico-chemical characterization and drug release initially and during accelerated stability study. The drug release was determined using fabricated continuous flow through cell apparatus. The difference between initial drug release and after three month drug release was 2.606% and the calculation was done for shelf life and found 2 years.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA